/People

Jean-François Formela

InvestorFounder

Partner at Atlas Venture · Founder at Korro Bio

Boston, Massachusetts, United States

Writes $500K – $5M checks · typically $2M

FoundedKorro Bio

Find your path to Jean-François

Sign up to see every warm intro you have to Jean-François

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Jean-François. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

Jean-François Formela is a partner at Atlas Venture, where he focuses on novel drug discovery technologies and therapeutics. He joined the firm in 1993 to establish its U.S. life sciences practice. He holds an M.D. from Paris University School of Medicine and an M.B.A. from Columbia University.

Contact· self-published, not guessed

Invests in

Biotech

Founder at Korro Bio

Intro paths

→

In turn, Jean-François can intro founders to Korro Bio's investors below.

Co-founders at Korro Bio

NBNessan Bermingham
Nessan BerminghamMr. Bermingham is the Executive Chair of the Issuer.

Deals · 12

Ikena Oncology, Inc.Board seat

via Atlas Venture · filed Jul 2025 · $75M raise

Scorpion TherapeuticsBoard seat

via Atlas Venture · filed Jul 2024 · $150M raise

Amagma, Inc.Board seat

via Atlas Venture · filed Dec 2022 · $10M raise

Spero TherapeuticsBoard seat

via Atlas Venture · filed Jul 2021 · $40M raise

IFM CinqueBoard seat

via Atlas Venture · filed Dec 2019

IFM ContinuaBoard seat

via Atlas Venture · filed Dec 2019

IFM QuattroBoard seat

via Atlas Venture · filed Dec 2019

Korro BioBoard seat

via Atlas Venture · filed Jun 2019 · $4M raise

RaNA TherapeuticsBoard seat

via Atlas Venture · filed May 2019 · $47.5M raise

IFM TreBoard seat

via Atlas Venture · filed Aug 2018

Navitor PharmaceuticalsBoard seat

via Atlas Venture · filed Dec 2015 · $33.3M raise

Intellia TherapeuticsBoard seat

via Atlas Venture · filed Sep 2015 · $70M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Board seats

Antares TherapeuticsAntares TherapeuticsIFM TherapeuticsIfmtheraIkena OncologyTranslate BioTriveni Bio

Investor

AdnexusAnnovation BioPharmaAntares TherapeuticsARCA biopharmaArQuleArteaus TherapeuticsAtaxionCoStim PharmaceuticalsDeCODE GeneticsEgaletExelixisF-Star TherapeuticsHorizon TherapeuticsIfmtheraNxStageTranslate BioTriplet TherapeuticsTriveni

Sources: SEC Form D filings · the firm's website · curated public sources.

Colleagues at Atlas Venture

Network1

Investors connected to Jean-François in public investor directories — a warm-intro map.

Frequently asked questions

Who is Jean-François Formela?
Jean-François Formela is a partner at Atlas Venture, where he focuses on novel drug discovery technologies and therapeutics. He joined the firm in 1993 to establish its U.S. life sciences practice. He holds an M.D. from Paris University School of Medicine and an M.B.A. from Columbia University.
Where does Jean-François Formela work?
Jean-François Formela is Founder of Korro Bio and Partner at Atlas Venture.
What does Jean-François Formela invest in?
Jean-François Formela invests in Biotech.
What check size does Jean-François Formela write?
Jean-François Formela typically writes checks of $500K – $5M.
What companies did Jean-François Formela found?
Jean-François Formela founded Korro Bio.
What boards does Jean-François Formela sit on?
Jean-François Formela holds tracked board seats at Amagma, Inc., Antares Therapeutics, Antares Therapeutics, IFM Cinque, IFM Continua, IFM Quattro, IFM Therapeutics, IFM Tre, Ifmthera, Ikena Oncology.
What companies has Jean-François Formela invested in?
Investments tracked here include Adnexus, Annovation BioPharma, Antares Therapeutics, ARCA biopharma, ArQule, Arteaus Therapeutics, Ataxion, CoStim Pharmaceuticals, DeCODE Genetics, Egalet, Exelixis, F-Star Therapeutics, and 10 more.

Founder mafias

About this profile. Compiled from public sources — Atlas Venture's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights